🔎 Trials Near Me

Avaleht › Interstitsiaalsed kopsuhaigused › Florida

Interstitsiaalsed kopsuhaigused kliinilised uuringud osariigis Florida

24 uuringut haiguse Interstitsiaalsed kopsuhaigused jaoks otsivad osalejaid osariigis Florida.

Linnad osariigis Florida

Ametlik uuringutekst (inglise keeles)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Clinical Research Specialists LLC - Kissimmee, Kissimmee
  • Lakeland Regional Medical Center - Lakeland, Lakeland
  • Advanced Pulmonary Research Institute, Loxahatchee Groves
  • ja veel 4
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • Clinical Research Specialists LLC - Kissimmee, Kissimmee
VärbamineFaas 3
Vanused 40 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA017, Gainesville
  • USA006, Naples
  • USA026, St. Petersburg
  • ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07179380

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Florida, Gainesville
  • New Access Research and Medical Services, Miami
  • Eunix Clinical Research, Orlando
  • ja veel 1
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 29. sept 2026 · NCT05798923

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

  • Clinical Research Site, Kissimmee
VärbamineFaas 3
Vanused 18–85 · Kõik sood · Uuendatud 11. sept 2026 · NCT07816185

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Gainesville
  • GSK Investigational Site, Naples
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Jacksonville
  • GSK Investigational Site, Miami
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • Cleveland Clinic Florida, Weston
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • AdventHealth Orlando, Orlando
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Tampa General Hospital, Tampa
VärbamineFaas 3
Vanused 18–80 · Kõik sood · Uuendatud 2. sept 2026 · NCT07285655

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Kissimmee
VärbamineFaas 2
Vanused 18–85 · Kõik sood · Uuendatud 2. sept 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Florida, Gainesville
  • NCH Research Institute, Naples
  • Advent Health Medical Group Advanced Lung Disease, Orlando
  • ja veel 3
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 26. aug 2026 · NCT06388421

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

  • University of Miami Hospital and Clinics, Miami
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT07486869

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Mayo Clinic Florida, Jacksonville
VärbamineFaas 2/3
Vanused 18–75 · Kõik sood · Uuendatud 17. aug 2026 · NCT06328777

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Florida, Gainesville
  • University of South Florida, Tampa
VärbamineVaatlusuuring
Vanused 21 ja vanemad · Kõik sood · Uuendatud 12. aug 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Mayo Clinic of Florida, Jacksonville
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 10. aug 2026 · NCT07175038

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

  • University of South Florida, Tampa
VärbamineFaas 2
Vanused 4 ja vanemad · Kõik sood · Uuendatud 22. juuli 2026 · NCT04925375

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
  • Mayo Clinic, Jacksonville
  • TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
  • ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. juuli 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Advent Health, Orlando
  • Tampa General Hospital Center of Research Excellence, Tampa
VärbamineVaatlusuuring
Vanused 18–80 · Kõik sood · Uuendatud 26. juuni 2026 · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

  • Mayo Clinic in Florida, Jacksonville
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 20. märts 2026 · NCT06751069

Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

  • Maule Stem Cell Research Institute, Venice
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. jaan 2026 · NCT07372989

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Florida Lung Asthma and Sleep Specialist, Celebration
  • Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 12. nov 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Miami
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 7. mai 2025 · NCT05892614

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.